Lilac Pharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

Lilac Pharma General Information

Description

Developer of microchannel devices intended for drug research and development. The company's technology provides manufacturing and product development technology for lipid and polymer nanoparticles used in various fields including pharmaceuticals, enabling organizations to access efficient devices for continuously producing various nanoparticle formulations.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Hokkaido University Campus Hokkaido Industry-Academia-Government Collaboration Center
  • Room C, Kita 21-jo Nishi 12-chome, Kita-ku
  • Sapporo, Hokkaido 001-0021
  • Japan
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Biotechnology
Parent Company
Corporate Office
  • Hokkaido University Campus Hokkaido Industry-Academia-Government Collaboration Center
  • Room C, Kita 21-jo Nishi 12-chome, Kita-ku
  • Sapporo, Hokkaido 001-0021
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lilac Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 09-Dec-2024 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Seed Round 17-Jan-2018 $88.9K $88.9K Completed Generating Revenue
1. Grant 01-Mar-2016 $306K Completed Generating Revenue
To view Lilac Pharma’s complete valuation and funding history, request access »

Lilac Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A
To view Lilac Pharma’s complete cap table history, request access »

Lilac Pharma Patents

Lilac Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024119170-A Pharmaceutical composition, method for producing pharmaceutical composition, and device for producing pharmaceutical composition Pending 22-Feb-2023
JP-2022052850-A Manufacturing method of emulsified perfume Pending 24-Sep-2020
JP-2020050635-A Biaryl sulfonamide derivative having inhibitory activity against cell invasion of filovirus Pending 28-Sep-2018
WO-2020067398-A1 Biaryl sulfonamide derivative having inhibitory activity against cell invasion of filovirus Inactive 28-Sep-2018

Lilac Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lilac Pharma Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hokkaido 21st Century Research Institute Venture Capital Minority
Hokuyo Capital Venture Capital Minority
New Energy and Industrial Technology Development Organization Government
Startup Hokkaido Accelerator/Incubator
To view Lilac Pharma’s complete investors history, request access »

Lilac Pharma FAQs

  • When was Lilac Pharma founded?

    Lilac Pharma was founded in 2016.

  • Where is Lilac Pharma headquartered?

    Lilac Pharma is headquartered in Sapporo, Japan.

  • What is the size of Lilac Pharma?

    Lilac Pharma has 10 total employees.

  • What industry is Lilac Pharma in?

    Lilac Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Lilac Pharma a private or public company?

    Lilac Pharma is a Private company.

  • What is Lilac Pharma’s current revenue?

    The current revenue for Lilac Pharma is .

  • How much funding has Lilac Pharma raised over time?

    Lilac Pharma has raised $88.9K.

  • Who are Lilac Pharma’s investors?

    Hokkaido 21st Century Research Institute, Hokuyo Capital, New Energy and Industrial Technology Development Organization, and Startup Hokkaido have invested in Lilac Pharma.

  • When was Lilac Pharma acquired?

    Lilac Pharma was acquired on 09-Dec-2024.

  • Who acquired Lilac Pharma?

    Lilac Pharma was acquired by Nippon Shokubai.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process